Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1696 to 1710 of 7682 results

  1. Dimethyl fumarate for treating relapsing-remitting multiple sclerosis in people aged 13 to 17 TS ID 11778

      Status ...

    Technology appraisal guidance
    Topic selection

  2. CT-P43 (ustekinumab biosimilar) for treating moderate to severe plaque psoriasis TS ID 11773

      Status ...

    Technology appraisal guidance
    Topic selection

  3. Crizotinib for treating ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour in people 6 to 17 years [TS ID 10574]

      Status ...

    Technology appraisal guidance
    Topic selection

  4. Selinexor for treating unresectable dedifferentiated advanced liposarcoma [ID3825]

    Awaiting development [GID-TA10694] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  5. Dusquetide for treating oral mucositis during chemoradiation for head and neck cancer [ID3830]

    Awaiting development [GID-TA10715] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  6. Lurbinectedin for treating advanced platinum-resistant ovarian cancer ID1340

    In development [GID-TA10313] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Palbociclib for treating high-risk early breast cancer after neoadjuvant chemotherapy [ID3846]

    Awaiting development [GID-TA10723] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Advocacy services for adults with health and social care needs

    Awaiting development [GID-QS10145] Expected publication date: TBC

    Quality standard
    Awaiting development

  9. Supporting independent living and preventing isolation in adults of working age with social care needs

    Awaiting development [GID-QS10149] Expected publication date: TBC

    Quality standard
    Awaiting development

  10. Total hip arthroplasty using the superpath approach for osteoarthritis

    In development [GID-IPG10204] Expected publication date: TBC

    Interventional procedures guidance
    In development

  11. Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]

    Awaiting development [GID-TA10776] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Timrepigene emparvovec for treating choroideremia [ID3916]

    Awaiting development [GID-TA10787] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912 ]

    Awaiting development [GID-TA10797] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Inolimomab (Leukotac) for acute Graft versus host disease (aGvHD) after Allo-HSCT [ID3923]

    Awaiting development [GID-TA10823] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. NY-ESO-1 T-cells for treating synovial sarcoma ID1286

    In development [GID-TA10205] Expected publication date: TBC

    Technology appraisal guidance
    In development